| 
 | 
EMD1214063
Chemical Information
    
        
            M.Wt
            492.57
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
LY2801653
Chemical Information
    
        
            M.Wt
            552.53
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
MK-8033
Chemical Information
    
        
            M.Wt
            471.53
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
BMS777607
Description of:BMS777607 
BMS777607 is a Small-Molecule Met Kinase Inhibitor with an IC50 of < 0.1 μM. Its treatment had little effect on ...
More>> 
 | 
 
 
             | 
          
| 
 | 
INCB28060
Description of:INCB28060 
Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c...
More>> 
 | 
 
 
             | 
          
| 
 | 
Foretinib(GSK1363089)
Description of:Foretinib(GSK1363089) 
GSK1363089 (XL880)is an orally bioavailable,small molecule MET/VEGFR2 inhibitor with potential antineoplas...
More>> 
 | 
 
 
             | 
          
| 
 | 
MGCD-265
Description of:MGCD-265 
MGCD265 is a tyrosine kinase inhibitor that targets the MET, VEGFR-1, VEGFR-2, VEGFR-3, RON and TIE2 receptor tyrosine ...
More>> 
 | 
 
 
             | 
          
| 
 | 
PHA-665752
Description of:PHA-665752 
M.Wt:641.61 
Formula:C32H34Cl2N4O4S 
Solubility:Soluble to 100 mM in DMSO 
Purity:>98 % 
S...
More>> 
 | 
 
 
             | 
          
| 
 | 
SU-11274
Description of:SU-11274 
SU11274 is a highly specific inhibitor of c-Met , with in vitro IC50 for the Met enzyme at 0.012 umol/L.  
...
More>> 
 | 
 
 
             | 
          
| 
 | 
SGX523
Description of:SGX523 
SGX-523, an orally bioavailable small molecule, specifically binds to c-Met protein, or hepatocyte growth factor receptor...
More>> 
 | 
 
 
             |